JPS58500392A - 微小気泡前駆体およびそれらの製造方法および用途 - Google Patents

微小気泡前駆体およびそれらの製造方法および用途

Info

Publication number: JPS58500392A
Authority: JP; Japan
Prior art keywords: liquid; microbubbles; solid; gas; precursor
Prior art date: 1980-11-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP50008082A

Other languages

English (en)

Japanese (ja)

Other versions

JPS6344731B2 (de

Inventor

レ−ザ−・ジユリア・エス

テイツクナ−・ア−ネスト・ジ−

Original Assignee

シエリング、アクテイエンゲゼルシヤフト

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-11-17

Filing date

1981-11-17

Publication date

1983-03-17

1981-11-17 Application filed by シエリング、アクテイエンゲゼルシヤフト filed Critical シエリング、アクテイエンゲゼルシヤフト

1981-11-17 Priority claimed from PCT/US1981/001526 external-priority patent/WO1982001642A1/en

1983-03-17 Publication of JPS58500392A publication Critical patent/JPS58500392A/ja

1988-09-06 Publication of JPS6344731B2 publication Critical patent/JPS6344731B2/ja

Status Granted legal-status Critical Current

Links

239000002243 precursor Substances 0.000 title claims description 199
238000004519 manufacturing process Methods 0.000 title claims description 14
239000007788 liquid Substances 0.000 claims description 212
239000007789 gas Substances 0.000 claims description 141
239000007787 solid Substances 0.000 claims description 131
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 56
238000000034 method Methods 0.000 claims description 51
239000002245 particle Substances 0.000 claims description 44
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 40
239000000203 mixture Substances 0.000 claims description 37
239000008280 blood Substances 0.000 claims description 31
210000004369 blood Anatomy 0.000 claims description 31
239000000463 material Substances 0.000 claims description 31
239000011780 sodium chloride Substances 0.000 claims description 30
229930182830 galactose Natural products 0.000 claims description 26
238000002604 ultrasonography Methods 0.000 claims description 26
238000012360 testing method Methods 0.000 claims description 22
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 20
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 20
239000000725 suspension Substances 0.000 claims description 15
239000008103 glucose Substances 0.000 claims description 11
231100000252 nontoxic Toxicity 0.000 claims description 11
230000003000 nontoxic effect Effects 0.000 claims description 11
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 10
230000005540 biological transmission Effects 0.000 claims description 10
230000017531 blood circulation Effects 0.000 claims description 10
239000012530 fluid Substances 0.000 claims description 10
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 8
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 8
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 8
150000001875 compounds Chemical class 0.000 claims description 8
230000002708 enhancing effect Effects 0.000 claims description 3
238000010790 dilution Methods 0.000 claims description 2
239000012895 dilution Substances 0.000 claims description 2
239000002552 dosage form Substances 0.000 claims description 2
239000007972 injectable composition Substances 0.000 claims description 2
238000005259 measurement Methods 0.000 claims description 2
239000011236 particulate material Substances 0.000 claims 9
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 2
230000000975 bioactive effect Effects 0.000 claims 2
239000008187 granular material Substances 0.000 claims 2
229940102213 injectable suspension Drugs 0.000 claims 2
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
239000011859 microparticle Substances 0.000 description 31
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 21
239000013078 crystal Substances 0.000 description 20
230000015572 biosynthetic process Effects 0.000 description 18
238000002347 injection Methods 0.000 description 18
239000007924 injection Substances 0.000 description 18
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
239000004033 plastic Substances 0.000 description 11
229920003023 plastic Polymers 0.000 description 11
150000003839 salts Chemical class 0.000 description 11
229920006395 saturated elastomer Polymers 0.000 description 11
239000002002 slurry Substances 0.000 description 11
238000007614 solvation Methods 0.000 description 11
239000000126 substance Substances 0.000 description 10
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
239000008121 dextrose Substances 0.000 description 9
239000006185 dispersion Substances 0.000 description 9
238000004090 dissolution Methods 0.000 description 9
239000007864 aqueous solution Substances 0.000 description 8
210000004204 blood vessel Anatomy 0.000 description 8
150000001720 carbohydrates Chemical class 0.000 description 8
239000002872 contrast media Substances 0.000 description 8
238000003384 imaging method Methods 0.000 description 8
230000001965 increasing effect Effects 0.000 description 8
239000000843 powder Substances 0.000 description 8
239000002244 precipitate Substances 0.000 description 8
239000000047 product Substances 0.000 description 8
229920001971 elastomer Polymers 0.000 description 7
239000000243 solution Substances 0.000 description 7
239000004094 surface-active agent Substances 0.000 description 7
238000007872 degassing Methods 0.000 description 6
238000002474 experimental method Methods 0.000 description 6
238000001953 recrystallisation Methods 0.000 description 6
241000282472 Canis lupus familiaris Species 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
230000000694 effects Effects 0.000 description 5
239000006260 foam Substances 0.000 description 5
230000006870 function Effects 0.000 description 5
238000002156 mixing Methods 0.000 description 5
239000011555 saturated liquid Substances 0.000 description 5
235000000346 sugar Nutrition 0.000 description 5
239000003981 vehicle Substances 0.000 description 5
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
238000010521 absorption reaction Methods 0.000 description 4
238000000498 ball milling Methods 0.000 description 4
210000004027 cell Anatomy 0.000 description 4
238000004581 coalescence Methods 0.000 description 4
239000008367 deionised water Substances 0.000 description 4
229910021641 deionized water Inorganic materials 0.000 description 4
239000010419 fine particle Substances 0.000 description 4
239000012528 membrane Substances 0.000 description 4
239000013081 microcrystal Substances 0.000 description 4
230000000704 physical effect Effects 0.000 description 4
238000001556 precipitation Methods 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
230000005855 radiation Effects 0.000 description 4
238000005185 salting out Methods 0.000 description 4
-1 sodium bitartrate Chemical class 0.000 description 4
239000002904 solvent Substances 0.000 description 4
238000003756 stirring Methods 0.000 description 4
238000003860 storage Methods 0.000 description 4
238000012285 ultrasound imaging Methods 0.000 description 4
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
108010010803 Gelatin Proteins 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
239000012298 atmosphere Substances 0.000 description 3
230000008901 benefit Effects 0.000 description 3
230000008859 change Effects 0.000 description 3
239000000806 elastomer Substances 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
239000008273 gelatin Substances 0.000 description 3
229920000159 gelatin Polymers 0.000 description 3
235000019322 gelatine Nutrition 0.000 description 3
235000011852 gelatine desserts Nutrition 0.000 description 3
239000011521 glass Substances 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
230000006641 stabilisation Effects 0.000 description 3
238000011105 stabilization Methods 0.000 description 3
210000003462 vein Anatomy 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
238000005481 NMR spectroscopy Methods 0.000 description 2
229910052782 aluminium Inorganic materials 0.000 description 2
VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
239000008365 aqueous carrier Substances 0.000 description 2
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
230000006399 behavior Effects 0.000 description 2
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
238000009835 boiling Methods 0.000 description 2
238000001514 detection method Methods 0.000 description 2
239000002612 dispersion medium Substances 0.000 description 2
238000009826 distribution Methods 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
230000002349 favourable effect Effects 0.000 description 2
MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 2
239000001257 hydrogen Substances 0.000 description 2
229910052739 hydrogen Inorganic materials 0.000 description 2
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
239000005457 ice water Substances 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
238000004898 kneading Methods 0.000 description 2
239000010410 layer Substances 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
210000002751 lymph Anatomy 0.000 description 2
210000003739 neck Anatomy 0.000 description 2
239000003921 oil Substances 0.000 description 2
235000019198 oils Nutrition 0.000 description 2
150000002894 organic compounds Chemical class 0.000 description 2
230000001151 other effect Effects 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
239000010421 standard material Substances 0.000 description 2
210000002784 stomach Anatomy 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
150000004043 trisaccharides Chemical class 0.000 description 2
230000000007 visual effect Effects 0.000 description 2
238000009736 wetting Methods 0.000 description 2
CTPDSKVQLSDPLC-UHFFFAOYSA-N 2-(oxolan-2-ylmethoxy)ethanol Chemical compound OCCOCC1CCCO1 CTPDSKVQLSDPLC-UHFFFAOYSA-N 0.000 description 1
NTJPVVKEZMOHNU-UHFFFAOYSA-N 6-(oxan-4-yl)-1h-indazole Chemical compound C1COCCC1C1=CC=C(C=NN2)C2=C1 NTJPVVKEZMOHNU-UHFFFAOYSA-N 0.000 description 1
238000012935 Averaging Methods 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
241000020091 Dicranocarpus parviflorus Species 0.000 description 1
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
238000004435 EPR spectroscopy Methods 0.000 description 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
239000005977 Ethylene Substances 0.000 description 1
101001093690 Homo sapiens Protein pitchfork Proteins 0.000 description 1
206010062717 Increased upper airway secretion Diseases 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
241000287462 Phalacrocorax carbo Species 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
102100036065 Protein pitchfork Human genes 0.000 description 1
MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
230000002009 allergenic effect Effects 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
238000013459 approach Methods 0.000 description 1
238000003491 array Methods 0.000 description 1
239000011324 bead Substances 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
230000005587 bubbling Effects 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
235000014171 carbonated beverage Nutrition 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
210000000748 cardiovascular system Anatomy 0.000 description 1
230000002490 cerebral effect Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
210000000038 chest Anatomy 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
238000003759 clinical diagnosis Methods 0.000 description 1
229910017052 cobalt Inorganic materials 0.000 description 1
239000010941 cobalt Substances 0.000 description 1
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
230000006835 compression Effects 0.000 description 1
238000007906 compression Methods 0.000 description 1
238000002591 computed tomography Methods 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
239000002285 corn oil Substances 0.000 description 1
210000004351 coronary vessel Anatomy 0.000 description 1
230000007547 defect Effects 0.000 description 1
210000001787 dendrite Anatomy 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
150000004862 dioxolanes Chemical class 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
239000000428 dust Substances 0.000 description 1
230000003628 erosive effect Effects 0.000 description 1
238000004880 explosion Methods 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
238000011049 filling Methods 0.000 description 1
238000005187 foaming Methods 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000000499 gel Substances 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
229940050410 gluconate Drugs 0.000 description 1
239000000174 gluconic acid Substances 0.000 description 1
235000012208 gluconic acid Nutrition 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
238000000227 grinding Methods 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
239000007970 homogeneous dispersion Substances 0.000 description 1
239000008240 homogeneous mixture Substances 0.000 description 1
238000005286 illumination Methods 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
150000002484 inorganic compounds Chemical class 0.000 description 1
229910010272 inorganic material Inorganic materials 0.000 description 1
238000007689 inspection Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
210000002570 interstitial cell Anatomy 0.000 description 1
238000007917 intracranial administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
230000001788 irregular Effects 0.000 description 1
239000008101 lactose Substances 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000006193 liquid solution Substances 0.000 description 1
230000004807 localization Effects 0.000 description 1
230000005291 magnetic effect Effects 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
239000002609 medium Substances 0.000 description 1
239000000155 melt Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
150000002772 monosaccharides Chemical class 0.000 description 1
235000019321 monosodium tartrate Nutrition 0.000 description 1
239000004570 mortar (masonry) Substances 0.000 description 1
210000004165 myocardium Anatomy 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
239000012299 nitrogen atmosphere Substances 0.000 description 1
239000002667 nucleating agent Substances 0.000 description 1
230000006911 nucleation Effects 0.000 description 1
238000010899 nucleation Methods 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
238000012856 packing Methods 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
230000008823 permeabilization Effects 0.000 description 1
208000026435 phlegm Diseases 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229940068886 polyethylene glycol 300 Drugs 0.000 description 1
229940068918 polyethylene glycol 400 Drugs 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
230000008569 process Effects 0.000 description 1
229960004063 propylene glycol Drugs 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000010791 quenching Methods 0.000 description 1
MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
239000002994 raw material Substances 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
238000002310 reflectometry Methods 0.000 description 1
238000005057 refrigeration Methods 0.000 description 1
230000002787 reinforcement Effects 0.000 description 1
238000012958 reprocessing Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
239000012047 saturated solution Substances 0.000 description 1
238000012216 screening Methods 0.000 description 1
239000013535 sea water Substances 0.000 description 1
239000008159 sesame oil Substances 0.000 description 1
235000011803 sesame oil Nutrition 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
230000008054 signal transmission Effects 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
239000002356 single layer Substances 0.000 description 1
239000002893 slag Substances 0.000 description 1
230000005061 slumber Effects 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
229940119126 sodium bitartrate Drugs 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
239000011343 solid material Substances 0.000 description 1
239000002195 soluble material Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
239000012798 spherical particle Substances 0.000 description 1
239000007858 starting material Substances 0.000 description 1
230000007847 structural defect Effects 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000002887 superconductor Substances 0.000 description 1
239000002344 surface layer Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
230000008719 thickening Effects 0.000 description 1
210000000779 thoracic wall Anatomy 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000002834 transmittance Methods 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
230000002861 ventricular Effects 0.000 description 1
239000000052 vinegar Substances 0.000 description 1
235000021419 vinegar Nutrition 0.000 description 1
210000001835 viscera Anatomy 0.000 description 1
239000011800 void material Substances 0.000 description 1
239000002351 wastewater Substances 0.000 description 1

Landscapes

Measuring And Recording Apparatus For Diagnosis (AREA)
Ultra Sonic Daignosis Equipment (AREA)

JP50008082A 1980-11-17 1981-11-17 微小気泡前駆体およびそれらの製造方法および用途 Granted JPS58500392A (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US207741		1980-11-17
PCT/US1981/001526 WO1982001642A1 (en)	1980-11-17	1981-11-17	Microbubble precursors and methods for their production and use

Publications (2)

Publication Number	Publication Date
JPS58500392A true JPS58500392A (ja)	1983-03-17
JPS6344731B2 JPS6344731B2 (de)	1988-09-06

Family

ID=22161509

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP50008082A Granted JPS58500392A (ja)	1980-11-17	1981-11-17	微小気泡前駆体およびそれらの製造方法および用途

Country Status (1)

Country	Link
JP (1)	JPS58500392A (de)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4265251A (en) *	1979-06-28	1981-05-05	Rasor Associates, Inc.	Method of determining pressure within liquid containing vessel
US4276885A (en) *	1979-05-04	1981-07-07	Rasor Associates, Inc	Ultrasonic image enhancement
US4277367A (en) *	1978-10-23	1981-07-07	Wisconsin Alumni Research Foundation	Phantom material and method

1981
- 1981-11-17 JP JP50008082A patent/JPS58500392A/ja active Granted

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4277367A (en) *	1978-10-23	1981-07-07	Wisconsin Alumni Research Foundation	Phantom material and method
US4276885A (en) *	1979-05-04	1981-07-07	Rasor Associates, Inc	Ultrasonic image enhancement
US4265251A (en) *	1979-06-28	1981-05-05	Rasor Associates, Inc.	Method of determining pressure within liquid containing vessel

Also Published As

Publication number	Publication date
JPS6344731B2 (de)	1988-09-06

Publication	Publication Date	Title
EP0052575B1 (de)	1986-01-08	Präparat zur Erzeugung von Mikrobläschen
US4442843A (en)	1984-04-17	Microbubble precursors and methods for their production and use
US4657756A (en)	1987-04-14	Microbubble precursors and apparatus for their production and use
US4681119A (en)	1987-07-21	Method of production and use of microbubble precursors
Miller et al.	1995	Ultrasound contrast agents nucleate inertial cavitation in vitro
AU627456B2 (en)	1992-08-27	Ultrasonic contrast medium made up of small gas bubbles and fatty-acid-containing microparticles
US5141738A (en)	1992-08-25	Ultrasonic contrast medium comprising gas bubbles and solid lipophilic surfactant-containing microparticles and use thereof
Sontum	2008	Physicochemical characteristics of Sonazoid™, a new contrast agent for ultrasound imaging
NZ207853A (en)	1988-01-08	Ultrasound contrast agent containing microparticles and gas micro-bubbles
EP0907380B1 (de)	2005-02-23	Druckbeständige protein-mikrosphäre als ultraschallkontrastmittel
DK165622B (da)	1992-12-28	Mikropartikel- og gasbobleholdigt ultralydskontrastmiddel samt udstyr og fremgangsmaade til dets fremstilling
JPH07505135A (ja)	1995-06-08	造影剤に関する改良
JPS6075437A (ja)	1985-04-27	超音波コントラスト剤とその製法
JP2000511510A (ja)	2000-09-05	造影剤のまたはそれに関する改良
JPS5879930A (ja)	1983-05-13	超音波診断用造影剤として使用する、生理学的に許容しうるガスで満たされた気泡の発生及び安定化用液体組成物及びその製造方法
JP6076555B1 (ja)	2017-02-08	バブル製造用容器
JP6547074B2 (ja)	2019-07-17	バブル保持剤含有液体およびバブル含有液体の製造方法
Wheatley et al.	1995	Structural studies on stabilized microbubbles: development of a novel contrast agent for diagnostic ultrasound
JPH08508257A (ja)	1996-09-03	超音波造影媒質としての微粒子
JP5927325B1 (ja)	2016-06-01	バブルの製造方法
US6217850B1 (en)	2001-04-17	Method of making lyophilized microbubble compositions useful as contrast agents
NZ281212A (en)	1998-06-26	Ultrasonic contrast medium: microparticles containing a substance that is gaseous at body temperature
JPS58500392A (ja)	1983-03-17	微小気泡前駆体およびそれらの製造方法および用途
JP3414894B2 (ja)	2003-06-09	超音波用造影剤及びその製造方法
NO163654B (no)	1990-03-19	Mikrobobleforloeper i steril, injiserbar enhetsdoseringsform, fremgangsmaate til fremstilling av en vandig suspensjonav mikrobobler og anvendelse av mikrobobleforloeperen for injisering i blodstroemmen hos et levende vesen.